Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 자연 획득 면역 대 백신 유도 면역, 재감염 대 돌발 감염: 후향적 코호트 연구Observational Study Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 임상, [키워드] 95% CI 95% confidence interval Acquired acquired immunity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 applied BNT162b2 BNT162b2 vaccine Breakthrough infection caused coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 delta variant demonstrated dominant dose Evidence evidence of examined Hospitalization Immunity increased risk individual individuals induced immunity infected individual infected individuals Infection inoculation mRNA BNT162b2 vaccine multivariate logistic regression Naturally naturally acquired immunity observational study occur occurred regimen Reinfection respiratory retrospective SARS-CoV-2 severe acute respiratory syndrome Coronavirus symptomatic disease vaccination Vaccine Vaccine-induced immunity vaccinee [DOI] 10.1093/cid/ciac262 PMC 바로가기 [Article Type] Observational Study
Single-Dose Messenger RNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Workers Extending 16 Weeks Postvaccination: A Test-Negative Design From Québec, Canada의료 종사자의 중증 급성 호흡기 증후군 코로나바이러스 2에 대한 단일 용량 메신저 RNA 백신 효과 백신 접종 후 16주 연장: 캐나다 퀘벡의 테스트 음성 디자인Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Against Alpha Analysis Canada Contact controls coronavirus coronavirus 2 COVID-19 defined determined by dose Effectiveness HCW HCWs healthcare healthcare worker Healthcare workers Hospitalization hospitalizations illness onset immunization likelihood Logistic regression messenger Messenger RNA mRNA mRNA vaccine outcome Patient postvaccination primary analysis provided public health Randomly recipient recipients respiratory RNA SARS-CoV-2 SARS-COV-2 infection second dose severe acute respiratory syndrome Coronavirus severity Single-dose specimen specimen collection stability Stratification Surveillance sustained test-negative design vaccination Vaccine vaccine effectiveness variants variants of concern VoC VOCs Week worker [DOI] 10.1093/cid/ciab739 PMC 바로가기 [Article Type] Article
Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada캐나다 영유아에서 SARS-CoV-2 감염의 임상 증상 및 질병 중증도Article Published on 2022-08-242022-09-11 Journal: PLoS ONE [Category] SARS, 치료기술, [키워드] absence acute COVID-19 age approved Asymptomatic Canada Care Characteristics Clinical management clinical manifestation clinical manifestations clinics Cohort comorbid condition comorbid conditions condition coryza cough COVID-19 criteria defined disease severity Fever help higher odd higher odds Hospitalization Hospitalized identify incidentally detected Infant Infants Infrastructure initial Inpatient Logistic regression main analysis microbiologically Mild moderate moderate or severe disease multivariable logistic regression National oral intake outcome Outpatient outpatients patient with SARS-CoV-2 presenting symptom Program Prospective Study Public health interventions reported SARS-CoV-2 SARS-COV-2 infection severe COVID-19 severe disease severity strain Vaccine was performed [DOI] 10.1371/journal.pone.0272648 PMC 바로가기 [Article Type] Article
Optimal Timing of Remdesivir Initiation in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Administered With Dexamethasone덱사메타손을 투여한 2019 코로나바이러스 질환(COVID-19) 입원 환자에서 렘데시비르 시작의 최적 시기Article Published on 2022-08-242022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] 95% CI acute respiratory distress addition applied benefit Clinical improvement Cohort coronavirus disease COVID-19 Cox regression models cumulative Dexamethasone difference drug exposure group Follow-up group hazard ratio Hong Kong hospital Hospital stay Hospitalization Hospitalized HRs IgG antibody In-hospital death increased risk initiated Initiation Length of hospital stay lower risk Multiple outcome Patient patients with moderate positive Probability progression Remdesivir significantly shorter Survivors syndrome time time to clinical improvement. Treatment Weighting were given WHO [DOI] 10.1093/cid/ciab728 PMC 바로가기 [Article Type] Article
Clinical and Genomic Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infections in mRNA Vaccinated Health Care Personnel in New York CityArticle Published on 2022-08-242022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 유전자 메커니즘, [키워드] acute respiratory syndrome B.1.617.2 Breakthrough infection breakthrough infections Cancer center characterization circulation clade clinical Clustering Cohort coronavirus coronavirus 2 death Delta dominant domination dose Effectiveness epidemiologic feature examined finding genomic hcp healthcare personnel Hospitalization Infection infections isolate laboratory-confirmed Messenger RNA moderate mRNA New York City occurred Post-vaccine respiratory Retrospective study SARS CoV-2 SARS-CoV-2 selection of variant Spread Strong study period Vaccine vaccine effectiveness variant WGS Whole genome sequencing [DOI] 10.1093/cid/ciab886 PMC 바로가기
Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021어린이의 다기관 염증 증후군 - 미국, 2020년 2월-2021년 7월Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age B.1.617.2 baseline cardiovascular complication cardiovascular complications case report form CDC center Child children Clinical outcome clinical outcomes Cochran-Armitage test continuous variables Control coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination Critical care death declined Delta demographics disease control duration of hospitalization dysfunction ECMO Epidemiology extracorporeal membrane oxygenation gastrointestinal involvement hematologic Hospitalization Hyperinflammatory inclusion criteria increase in Infection Inflammatory information interquartile range Laboratory results male predominance mechanical ventilation median MIS-C Mortality multisystem inflammatory syndrome in children myocarditis National other variant other variants over pandemic Patient patient age prevention receipt renal renal failure reported SARS-CoV-2 study period Surveillance syndrome The United States These data trend United States variables were assessed [DOI] 10.1093/cid/ciab1007 PMC 바로가기 [Article Type] Article
Inactivated vaccine injection and immunoglobulin G levels related to severe coronavirus disease 2019 (Delta) pneumonia in Xi’an, China: A single-centered, retrospective, observational studyArticle Published on 2022-08-232022-11-15 Journal: Frontiers in Cellular and Infection Microbiology [Category] SARS, 변종, 진단, [키워드] acute respiratory syndrome analyzed B.1.617.2 booster booster shot Chinese coronavirus coronavirus disease COVID-19 COVID-19 severity Critical death Delta delta variant effective Efficacy Epidemic evaluate Hospitalization IgG antibody IgG level immune response Immunoglobulin Immunoglobulin G Inactivated vaccine Infection infections injection International logistic regressions men Mild moderate Older Patient patients with COVID-19 Pneumonia PROTECT protective effect public health emergency retrospective Retrospective study risk severe cases severe coronavirus disease severity underlying diseases Vaccine vaccine injection World Health Organization [DOI] 10.3389/fcimb.2022.933100 PMC 바로가기
Genetic predispositions to psychiatric disorders and the risk of COVID-19정신 질환에 대한 유전적 소인과 COVID-19의 위험Article Published on 2022-08-232022-09-11 Journal: BMC Medicine [Category] 변종, [키워드] 95% CI 95% confidence interval adjusted odds ratio analyses Analysis Anxiety ascertainment association calculated coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 case COVID-19 cases COVID-19 pandemic dataset death death records Depression disorder disorders examined Factor Genetic genetic factors Genetic predisposition genetic risk Genetic variant Genome-wide association study GWAS GWAS summary statistics hospital Hospitalization increased risk individual Logistic regression participant performed phenotype phenotypic predisposition PRS Psychiatric psychiatric disorder Psychiatric disorders Psychiatric disorders. psychotic disorder Public Health England Randomly repeated risk risk of COVID-19 selected severe cases severe COVID-19 stress-related disorders study population Surveillance UK biobank vulnerable population were used [DOI] 10.1186/s12916-022-02520-z PMC 바로가기 [Article Type] Article
Association of Different Malnutrition Parameters and Clinical Outcomes among COVID-19 Patients: An Observational StudyObservational Study Published on 2022-08-222022-10-05 Journal: Nutrients [Category] 임상, [키워드] 95% CI adjusted Admission age albumin albumin level Analysis analyzed association body mass index clinical Clinical outcome Comorbidity COVID-19 died Future Gender high risk Hospitalization Hospitalized In-hospital in-hospital mortality in-hospital outcomes increase in increased risk Inpatient IQR male Malnutrition median median age moderate Mortality mortality risk multivariable no risk nutritional risk screening 2002. Odds ratio parameter Patient patient population patients hospitalized patients with COVID-19 prevalent prognostic Regression analyses regression analysis Result risk risk factor Screening secondary endpoint Switzerland Treatment with COVID-19 [DOI] 10.3390/nu14163449 PMC 바로가기 [Article Type] Observational Study
Anti-SARS-CoV-2 seroprevalence in King County, WA-Cross-sectional survey, August 2020킹 카운티, WA-단면 조사, 2020년 8월의 Anti-SARS-CoV-2 혈청 유병률Article Published on 2022-08-222022-09-11 Journal: PLoS ONE [Category] SARS, 진단, 치료법, [키워드] 95% confidence interval Accuracy age all age groups anti-SARS-CoV-2 antibody best cause children conducted COVID-19 cross-sectional dried blood spot Dried blood spots effective sample size Factor FIVE highest Hispanic Hospitalization Household survey Households Immunoglobulin Immunoglobulin G incidence income Infection King lowest Older participant Positive test Prevalence proportion Protein provided random SARS-CoV-2 Seroprevalence seroprevalence survey Seven Sex Spike protein statistically significant tested the spike protein the viral nucleocapsid Viral viral nucleocapsid protein virus Weighting white [DOI] 10.1371/journal.pone.0272783 PMC 바로가기 [Article Type] Article